CNS2024

Chronic Inflammatory Demyelinating Polyneuropathy: Pathophysiology, Diagnosis, and New and Emerging Treatment Options

Saturday, November 2nd, 2024 from 5:00pm – 6:00pm PDT

Name:

First NameLast Name

Credentials:

State Licensed to Practice in:

Email:

example@example.com

1. A diagnosis of CIDP can be confidently made if:

2. The pathophysiologic process of CIDP:

3. In the ADHERE Trial:

Please rate the extent to which this activity met the following objectives:

Rows	Poor	Fair	Good	Very Good	Excellent
Review the pathophysiology and disease burden of CIDP, the role of IgG autoantibodies, accurate patient identification and diagnosis, and the limitations of current treatments.
Analyze recent clinical trial data on new and emerging biologic treatments for CIDP and be prepared to contextualize these data into their practices.
Develop individualized treatment plans for CIDP based on patient prognosis, a review of treatment options, an assessment of safety, familiarity with current treatment guidelines, and shared decision making.

Please provide us with feedback regarding your experience at the activity:

Please rate the faculty on his overall teaching ability:

Rows	Poor	Fair	Good	Very Good	Excellent
Perry B. Shieh, MD

Do you feel this activity was fair balanced and free of commercial bias?

If no, please explain:

This educational activity will result in a change in my role as a healthcare team member.

Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:

What factors beyond clinical care that effect the health of your patients does your team experience?

courseTitle

credit-amount

Overall Activity Feedback